RLAY FY 2023 Earnings — Relay Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

RLAYRelay Therapeutics, Inc.

$2B

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$26M+1749.8% YoY

Gross Profit

$26M100.0% margin

Operating Income

-$373M-1460.1% margin

Net Income

-$342M-1338.7% margin

EPS (Diluted)

$-2.79

Cash Flow

Operating Cash Flow

-$300M

Free Cash Flow

-$304M

Stock-Based Comp.

$86M

Balance Sheet

Total Assets

$844M

Total Liabilities

$92M

Stockholders' Equity

$752M

Cash & Equivalents

$144M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$26M	$1M	+1749.8%
Gross Profit	$26M	$1M	+1749.8%
Operating Income	-$373M	-$299M	-24.6%
Net Income	-$342M	-$291M	-17.7%